Bevacizumab inhibits breast cancer-induced osteolysis, surrounding soft tissue metastasis, and angiogenesis in rats as visualized by VCT and MRI. (Q36640234)
Jump to navigation
Jump to search
scientific article published on May 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bevacizumab inhibits breast cancer-induced osteolysis, surrounding soft tissue metastasis, and angiogenesis in rats as visualized by VCT and MRI. |
scientific article published on May 2008 |
Statements
1 reference
Bevacizumab inhibits breast cancer-induced osteolysis, surrounding soft tissue metastasis, and angiogenesis in rats as visualized by VCT and MRI. (English)
1 reference
Stefan Delorme
1 reference
Tobias Bäuerle
1 reference
Heidegard Hilbig
1 reference
Sönke Bartling
1 reference
Fabian Kiessling
1 reference
Astrid Kersten
1 reference
Martin R Berger
1 reference
1 May 2008
1 reference
1 reference
511-520
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference